Related Experiment Video
Updated: Jun 26, 2025

Novel Passive Clearing Methods for the Rapid Production of Optical Transparency in Whole CNS Tissue
Published on: May 8, 2018
Tissue distribution and retention drives efficacy of rapidly clearing VHL-based PROTACs
Donglu Zhang1, Bin Ma2, Peter S Dragovich2
1Genentech; 1 DNA Way, South San Francisco, CA, 94080, USA. zhang.donglu@gene.com.
Background:
Proteolysis-targeting chimeras (PROTACs) are being developed for therapeutic use. However, they have poor pharmacokinetic profiles and their tissue distribution kinetics are not known.
Methods:
A typical von Hippel-Lindau tumor suppressor (VHL)-PROTAC 14C-A947 (BRM degrader)-was synthesized and its tissue distribution kinetics was studied by quantitative whole-body autoradiography (QWBA) and tissue excision in rats following IV dosing. Bile duct-cannulated (BDC) rats allowed the elucidation of in vivo clearance pathways. Distribution kinetics was evaluated in the tissues and tumors of mice to support PK-PD correlation. In vitro studies enabled the evaluation of cell uptake mechanisms and cell retention properties.
Results:
Here, we show that A947 quickly distributes into rat tissues after IV dosing, where it accumulates and is retained in tissues such as the lung and liver although it undergoes fast clearance from circulation. Similar uptake/retention kinetics enable tumor growth inhibition over 2-3 weeks in a lung cancer model. A947 quickly excretes in the bile of rats. Solute carrier (SLC) transporters are involved in hepatocyte uptake of PROTACs. Sustained BRM protein degradation is seen after extensive washout that supports prolonged cell retention of A947 in NCI-H1944 cells. A947 tissue exposure and pharmacodynamics are inversely correlated in tumors.
Conclusions:
Plasma sampling for VHL-PROTAC does not represent the tissue concentrations necessary for efficacy. Understanding of tissue uptake and retention could enable less frequent IV administration to be used for therapeutic dosing.
Insights
Proteolysis-targeting chimeras (PROTACs) distribute rapidly into tissues, accumulating in organs like the lung and liver. Understanding this tissue distribution is key for optimizing PROTAC therapeutic dosing and efficacy.
Area of Science:
- Pharmacology
- Biochemistry
- Oncology
Background:
- Proteolysis-targeting chimeras (PROTACs) are emerging therapeutics with potential clinical applications.
- However, their poor pharmacokinetic profiles and unknown tissue distribution kinetics hinder development.
Purpose of the Study:
- To investigate the tissue distribution kinetics of a VHL-PROTAC (14C-A947) in rats and mice.
- To elucidate in vivo clearance pathways and evaluate cell uptake/retention mechanisms.
Main Methods:
- Quantitative whole-body autoradiography (QWBA) and tissue excision in rats and mice following IV dosing.
- Bile duct-cannulated (BDC) rats were used to determine clearance pathways.
- In vitro studies assessed cell uptake and retention properties.
Main Results:
- 14C-A947 rapidly distributed into rat tissues, accumulating in the lung and liver despite fast systemic clearance.
- Tumor growth inhibition was observed in a lung cancer model, correlating with tissue uptake/retention kinetics.
- Solute carrier (SLC) transporters mediate hepatocyte uptake, and sustained protein degradation occurred due to prolonged cell retention.
Conclusions:
- Plasma concentrations do not accurately reflect tissue concentrations for VHL-PROTAC efficacy.
- Understanding PROTAC tissue uptake and retention is crucial for optimizing therapeutic dosing strategies, potentially allowing less frequent administration.
Related Concept Videos
Drug Distribution: Tissue Binding
For...
Tissue-Drug Binding: Localization of Drugs and its Significance
Drugs can bind to different tissue components, enhancing their distribution and localization. The factors influencing drug localization in tissues include the drug's lipophilicity, structural characteristics, tissue perfusion rate, and pH differences. These factors determine...
Hepatic Drug Clearance: Effect of Protein Binding
For low-extraction-ratio drugs that are less than 80% protein-bound, minor changes in protein binding...
Factors Affecting Renal Clearance: Drug Distribution and Drug Interactions
One important factor is the relationship between renal clearance and the apparent volume of distribution. Renal clearance tends to be inversely proportional to the apparent volume of distribution. Drugs with an extensive distribution volume or those...
Hepatic Drug Clearance: Role of Transporters
Drug Distribution: Volume of Distribution

